Search

Filters
Clear All
  • 20
  • 60
  • 2
  • 631

Phase

  • 1
  • 14
  • 14
  • 50
  • 6
  • 77
  • 5
  • 536
  • 649
  • 288

Found 713 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

B
Brian Mullis, MD
18 years - 80 years
All genders
Phase 3
Interventional
The overall objective is to compare the effect of Vancomycin and Tobramycin powder combined (treatment) to Vancomycin powder (control) in the reduction of post-fixation infections ofbial plateau and tibial pilon fractures at high risk of infection (collectively consideredhe "study injuries").
C
Christina M. Scifres, MD
18 years - 45 years
Female
Interventional
This is a multicenter randomized clinical trial of 828 overweight and obese individuals with gestational diabetes designed to compare standard to intensive glycemic targets.
K
Kathryn Haider, MD
6 months or below
All genders
Phase 2
Interventional
What is the purpose of this study?Type 1 retinopathy of prematurity in zone I represents the most severe type of ROP and hashe worst prognosis. It is unknown whether low-dose bevacizumab will be successful in the severe cases. Also unknown is the timing and extent of peripheral retinal vascularizationw-dose bevacizumab …
S
Sabah D. Butty, MD
18 years or above
All genders
Interventional
The purpose of this study is to determine if the use of image-guided, endovascular therapy (EVT) is an effective strategy with which to reduce Post Thrombotic Syndrome (PTS) diseaseverity and improve quality of life in patients with established disabling iliac-obstructivehrombotic syndrome (DIO-PTS).
A
Ashay D. Bhatwadekar, PhD, MPHARM
18 years or above
All genders
Observational
What is the purpose of this study?Diabetic retinopathy is characterized by damage to retinal blood vessels. At present, there is no diagnostic marker reflecting retinal vascular health. By studying RNA content (genetic material that makes proteins) in highly specialized cells in circulating blood resembling blood vessels, we will discover biomarker …
D
David Clark
18 years or above
Accepts healthy volunteer
All genders
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents thezed integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD2019 and beyond.
J
John Parent, MD
7 years or above
Male
Phase 2
Interventional
Duchenne muscular dystrophy (DMD) is a devastating X-linked disease which leads to loss ofbulation between ages 7 and 13, respiratory failure and cardiomyopathy (CM) at any age, andvitably premature death of affected young men in their late twenties. DMD is the mostgenetic disorder diagnosed in childhood. It affects approximately 1 …
L
Lisa Landrum, MD, PhD, MS
18 years or above
Female
Phase 3
Interventional
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary,ube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount ofgen made by the body which in turn may stop the growth …
N
Noel Dasgupta
18 years or above
All genders
Phase 3
Interventional
The purpose of this study is to evaluate the safety and tolerability of extended dosing withwith hereditary transthyretin-mediated amyloid polyneuropathy (hATTR-PN).
C
Craig Lammert, MD
18 years or above
All genders
Phase 1/2
Interventional
The primary objectives of this study are to evaluate the safety of single IV doses of UX701with Wilson disease, to select the UX701 dose with the best benefit/risk profile based on the totality of safety and efficacy data and to evaluate the effect of UX701 ongulation.
471 - 480 of 713